ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP, Wang YY, Liu D, Lei HY, Yang ZH, Zhang ZW, Han M, Cheng K, Chen YS, Li JQ, Cheng GR, Xu L, Wu QM, McClintock SM, Yang Y, Zhang Y, Zeng Y.
Pei YP, et al. Among authors: mcclintock sm.
J Neurosci. 2020 Feb 5;40(6):1355-1365. doi: 10.1523/JNEUROSCI.2626-18.2019. Epub 2019 Dec 27.
J Neurosci. 2020.
PMID: 31882402
Free PMC article.